— Know what they know.
Not Investment Advice
Also trades as: ACON (NASDAQ) · $vol 0M

ACONW NASDAQ

Aclarion, Inc.
1W: +16.7% 1M: -5.4% 3M: +12.4% YTD: -19.8% 1Y: -33.6% 3Y: -80.7%
$0.03
+0.00 (+0.67%)
 
Weekly Expected Move ±64.4%
$-0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 34 · $15999 mcap · 533279 float · 4.95% daily turnover · Short 80% of daily vol

Supply Chain Overview

7 relationships
7
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-04-27
Earliest Filing
2024-11-27
Latest Filing
partner: 3 investor: 2 customer: 1 target: 1

Counterparties (Filed by ACONW)

7 relationships

Companies named in ACONW's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
White Lion Capital, LLC — investor Entered into an equity line purchase agreement and related registration rights agreement with Aclarion, Inc. 2024-11-27 View
AXA AXTA customer AXA provided initial payer coverage for Aclarion's Nociscan product in the greater London, U.K. area. 2024-06-26 View
Maxim Group LLC MMS partner Placement agent for the registered public offering of Units 2024-02-27 View
Vstock Transfer LLC — partner Transfer agent for the common and prefunded warrants 2024-02-27 View
Aclarion, Inc. ACONW target Issuer of common stock in the purchase agreement 2023-10-10 View
White Lion Capital, LLC — investor Investor purchasing common stock from the company 2023-10-10 View
VStock Transfer LLC — partner Transfer agent for the warrants issued in the offering 2022-04-27 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-06-04 Shareholder Vote View
2026-04-22 Other Events; Exhibits View
2026-01-13 Regulation FD Disclosure; Financial Statements and Exhibits View
2026-01-09 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-10-14 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-09-03 Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; Agreement View
2025-07-21 Submission of Matters to a Vote of Security Holders View
2025-07-07 Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements View
2025-06-20 Departure/Election of Directors; Appointment of Officers View
2025-04-23 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-03-28 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-03-13 Other Events View
2025-03-06 Submission of Matters to a Vote of Security Holders View
2025-02-28 Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements View
2025-01-31 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-01-30 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-01-17 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-01-06 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-01-03 Submission of Matters to a Vote of Security Holders View
2025-01-03 Termination of Material Definitive Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms